Browsing Tag
Gujarat Themis Biosyn Limited
2 posts
Can Gujarat Themis Biosyn turn a Japanese acquisition into a global CDMO platform?
Gujarat Themis Biosyn is buying MicroBiopharm Japan for ₹1,300 crore. Find out why this CDMO bet matters for #GUJTHEM today!
May 25, 2026
Gujarat Themis Biosyn (GUJTHEM) bets on global branded generics with €158m Sanofi portfolio deal
Find out how Gujarat Themis Biosyn’s €158m Sanofi portfolio deal could reshape its global anti-infective growth strategy.
April 24, 2026